Regulatory Expectations for mRNA Therapeutics and Vaccines

Time: 9:30 am
day: Conference Day Two

Details:

  • UK regulatory perspectives on marketing authorisation applications
  • What do regulators look for in the characterisation and manufacturing control of mRNA therapeutics?
  • Applying this information to your own licensing applications with the MHRA

Speakers: